Home › Kidney Cancer (Renal Cell Carcinoma) › Wisconsin › Racine
Kidney Cancer (Renal Cell Carcinoma) clinical trials in Racine, WI
4 studies for Kidney Cancer (Renal Cell Carcinoma) are looking for participants at sites in and around Racine (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RecruitingObservational studyHealthy volunteers welcome
- Aurora Cancer Care-Racine, Racine
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
RecruitingPhase 2
- Aurora Cancer Care-Racine, Racine
Testing the Addition of the Anti-Cancer Drug Tivozanib to Immunotherapy (Pembrolizumab) After Surgery to Remove All Known Sites of Kidney Cancer
RecruitingPhase 3
- Aurora Cancer Care-Racine, Racine
Comparing the Outcome of Immunotherapy-Based Drug Combination Therapy With or Without Surgery to Remove the Kidney in Metastatic Kidney Cancer, the PROBE Trial
RecruitingPhase 3
- Aurora Cancer Care-Racine, Racine
Kidney Cancer (Renal Cell Carcinoma) trials in other cities
- Houston, TX35 studies
- New York City, NY27 studies
- Nashville, TN23 studies
- Dallas, TX23 studies
- St. Louis, MO23 studies
- Los Angeles, CA20 studies
- Boston, MA16 studies
- Baldwin Park, CA16 studies
- Pittsburgh, PA15 studies
- Philadelphia, PA15 studies
- Queens, NY15 studies
- Cleveland, OH14 studies
Other studies in Racine
- Lung Cancer7 studies
- Non-Small Cell Lung Cancer6 studies
- Colorectal Cancer5 studies
- Breast Cancer4 studies
- Prostate Cancer4 studies
- Bladder Cancer4 studies
- Cancer (all types)3 studies
- Ovarian Cancer3 studies
- Head and Neck Squamous Cell Carcinoma3 studies
- Colon Cancer3 studies
- Pancreatic Cancer3 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.